DoriVac

N/A

Report date: 2024/05/28 16:37:10

Base Information

Drug NameDoriVac
Drug Alias NameN/A
ClassificationVaccines > Vaccine type > Combination vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLung NeoplasmsColonic NeoplasmsMelanoma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWyss Institute At Harvard University
China Registration ClassN/A

Develop Information

Active CompaniesWyss Institute At Harvard University
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsColonic NeoplasmsMelanoma +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A